Expression analysis in the human breast cancer METABRIC data set and in the autochthonous PyMT x MOLF/EiJ backcross tumor samples indicated that lower expression of Resf1 was associated with worse outcomes. This evidence concerns the gene RESF1 and breast carcinoma.